QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, May 14, 2008, 28(20):5312-5320; doi:10.1523/JNEUROSCI.1042-08.2008

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Related articles in J. Neurosci. Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Xu, F. Articles by Van Nostrand, W. E. Search for Related Content PubMed PubMed Citation Articles by Xu, F. Articles by Van Nostrand, W. E.

 Previous Article  |  Next Article 

Neurobiology of Disease
Human Apolipoprotein E Redistributes Fibrillar Amyloid Deposition in Tg-SwDI Mice

Feng Xu,¹ Michael P. Vitek,² Carol A. Colton,² Mary Lou Previti,¹ Nastaran Gharkholonarehe,² Judianne Davis,¹ and William E. Van Nostrand¹

¹Department of Medicine, Stony Brook University, Stony Brook, New York 11794-8153, and ²Division of Neurology, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710

Correspondence should be addressed to Dr. William E. Van Nostrand, Department of Medicine, HSC T-15/083, Stony Brook University, Stony Brook, NY 11794-8153. Email: william.vannostrand{at}stonybrook.edu

Human apolipoprotein (ApoE) genotype influences the development of Alzheimer's disease and cerebral amyloid angiopathy (CAA). Specific mutations within the amyloid-β protein (Aβ) peptide have been identified that cause familial forms of CAA. However, the effect of APOE genotype on accumulation of CAA mutant Aβ in brain is not well understood. In the present study, we determined how human ApoE3 or ApoE4 influence cerebral Aβ accumulation in transgenic mice (Tg-SwDI) that accumulate human Dutch/Iowa (E22Q/D23N) CAA mutant Aβ in brain, primarily in the form of fibrillar cerebral microvascular amyloid. Using Tg-SwDI mice bred onto a human APOE3/3 or human APOE4/4 background, we found that both human ApoE3 and ApoE4 proteins led to a strong reduction in the amount of cerebral microvascular amyloid with an unexpected concomitant appearance of extensive fibrillar parenchymal plaque amyloid. There was strong colocalization of all ApoE proteins with fibrillar amyloid deposits in the mice. In Tg-SwDI/hAPOE3/3 and Tg-SwDI/hAPOE4/4 mice, there was no change in the levels of total Aβ₄₀ and Aβ₄₂ or in the amounts of soluble and insoluble Aβ in brain compared with Tg-SwDI mice on the endogenous mouse APOE background. The shift from primarily cerebral microvascular amyloid to parenchymal plaque amyloid in Tg-SwDI/hAPOE3/3 and Tg-SwDI/hAPOE4/4 mice resulted in a parallel shift in the association of activated microglia. These findings indicate that human ApoE has a strong influence on the spatial development of human Dutch/Iowa CAA mutant amyloid accumulation in mouse brain and that microglial activation is in response to the spatial accumulation of fibrillar amyloid.

Key words: amyloid β protein; apolipoprotein E; transgenic mice; cerebral vasculature; Alzheimer's disease; microglia

---

Received Jan. 11, 2008; accepted April 2, 2008.

Correspondence should be addressed to Dr. William E. Van Nostrand, Department of Medicine, HSC T-15/083, Stony Brook University, Stony Brook, NY 11794-8153. Email: william.vannostrand{at}stonybrook.edu

Related articles in J. Neurosci.:

This Week in The Journal

J. Neurosci. 2008 28: i. [Full Text]  

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help